As Biogen grapples with coronavirus crisis, Big Pharmas like Eli Lilly, Takeda hunker down, tell staffers to work from home
With the number of coronavirus cases spiraling upwards over the weekend at Biogen, other biopharma companies are hunkering down and adding new precautionary measures to help prevent infections on staff.
A spokesperson for Takeda — which has a big presence in the Boston/Cambridge area since closing the Shire buyout — tells me that they adopted new work guidelines on Sunday. And Indianapolis-based Eli Lilly reportedly did the same after 2 attendees at the Biogen meeting returned to Indiana with the new coronavirus. Lilly sent out word on Sunday that staffers should work remotely if at all possible, according to the Indianapolis Star.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 77,300+ biopharma pros reading Endpoints daily — and it's free.